130 North Bellefield Avenue, Suite 546 — Pittsburgh, Pennsylvania

130 North Bellefield Avenue, Suite 546 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

130 North Bellefield Avenue, Suite 546 has participated in 1 clinical trials.

Therapeutic areas: Atherosclerosis, Coronary Arteriosclerosis, Coronary Disease.

Sponsors: University of Pittsburgh.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 130 North Bellefield Avenue, Suite 546?

130 North Bellefield Avenue, Suite 546 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 130 North Bellefield Avenue, Suite 546 conducted?

130 North Bellefield Avenue, Suite 546 has 1 clinical trials on record. Their work covers Atherosclerosis, Coronary Arteriosclerosis, Coronary Disease.

Is 130 North Bellefield Avenue, Suite 546 accredited by Crixeo Health?

130 North Bellefield Avenue, Suite 546 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 130 North Bellefield Avenue, Suite 546?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.